Related Experiment Video

Updated: Apr 28, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

13.1K

BxPC3 pancreatic cancer cells express a truncated Smad4 protein upon PI3K and mTOR inhibition

Onica Legendre1, Ayisha Sookdeo1, David A Foster1

  • 1Department of Biological Sciences, Hunter College of The City University of New York, New York, NY 10065, USA.

Oncology Letters
|June 20, 2014
PubMed

Insights

Smad4 protein is expressed in BxPC3 pancreatic cancer cells, but functions abnormally due to translocation, not deletion. This finding challenges the use of BxPC3 as a Smad4-null model.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Smad4 is a key regulator of transforming growth factor-beta (TGF-β) signaling.
  • Smad4 defects are common in human cancers, particularly pancreatic cancer (30% of cases).
  • The BxPC3 cell line is widely used as a Smad4-null model, presumed to have a homozygous deletion.

Purpose of the Study:

  • To investigate the status of Smad4 in BxPC3 cells.
  • To clarify the mechanism of Smad4 dysfunction in this pancreatic cancer model.

Main Methods:

  • Analysis of Smad4 DNA presence in BxPC3 cells.
  • Investigation of Smad4 protein expression under suppressed mTORC1 and PI3K signaling.
  • Assessment of TGF-β response in BxPC3 cells.

Main Results:

  • Smad4 DNA is present in BxPC3 cells.
  • A truncated Smad4 protein is expressed under specific signaling conditions (suppressed mTORC1 and PI3K).
  • BxPC3 cells do not respond to TGF-β despite potential Smad4 protein expression.

Conclusions:

  • The Smad4 defect in BxPC3 cells is likely due to translocation, not a homozygous deletion.
  • BxPC3 cells are not truly Smad4-null and may not be an appropriate model for studying Smad4 loss-of-function.
  • Re-evaluation of Smad4's role in pancreatic cancer models is warranted.
Keywords:
BxPC3 cellsSmad4chromosomal instabilitypancreatic cancertransforming growth factor-β

More Related Videos

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis07:26

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis

Published on: January 31, 2025

1.1K
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

12.8K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.1K